Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for certain skin and lung cancers.

Having an mRNA COVID vaccine will not make your body produce new tumour-fighting T cells. What it might do, based on this ...

Noubar Afeyan tells the STAT Summit that political moves to replace facts with opinions won't stop with mRNA vaccines. "It’s ...

Researchers from The University of Osaka in collaboration with Baylor College of Medicine have developed a new therapy for a ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Deborah Fuller, University of Washington (THE CONVERSATION) At a Sept. 4, 2025, ...

University of Florida researchers found that advanced lung and skin cancer patients lived “significantly longer” after ...

On Sept. 4, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. is scheduled to testify before the Senate Finance Committee, where he is expected to face questions about his vaccine ...

Moderna MRNA shares rallied 13.9% in the last trading session to close at $28.14. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session.